Showing results (91-100 of 382) with videos related to
Sort By:
Pageof 39
Tomography (Ann Arbor, Mich.)|April 3, 2021
Dynamic Contrast Enhanced-MR CEST Urography: An Emerging Tool in the Diagnosis and Management of Upper Urinary Tract ObstructionShaowei Bo, Farzad Sedaghat, KowsalyaDevi Pavuluri, et al.International Journal of Cancer|February 4, 2018
Arsenic promotes the COX2/PGE2-SOX2 axis to increase the malignant stemness properties of urothelial cellsAkira Ooki, Asma Begum, Luigi Marchionni, et al.BJU International|June 7, 2014
Indications for intervention during active surveillance of prostate cancer: a comparison of the Johns Hopkins and Prostate Cancer Research International Active Surveillance (PRIAS) protocolsMax Kates, Jeffrey J Tosoian, Bruce J Trock, et al.Immunology and Cell Biology|March 2, 2011
Resolution of infection promotes a state of dormancy and long survival of CD4 memory T cellsSarat K Dalai, Stanislav Khoruzhenko, Charles G Drake, et al.Oncology (Williston Park, N.Y.)|May 17, 2015
Stereotactic radiation therapy combined with immunotherapy: augmenting the role of radiation in local and systemic treatmentAndrew B Sharabi, Phuoc T Tran, Michael Lim, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 5, 2006
Cutting Edge: TCR-induced NAB2 enhances T cell function by coactivating IL-2 transcriptionSamuel Collins, Lawrence A Wolfraim, Charles G Drake, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2011
Prostate cancer immunotherapyKenneth F May, James L Gulley, Charles G Drake, et al.Journal for Immunotherapy of Cancer|June 3, 2014
Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primerRaju R Raval, Andrew B Sharabi, Amanda J Walker, et al.Urologic Oncology|August 1, 2016
Lymph node yield and tumor location in patients with upper tract urothelial carcinoma undergoing nephroureterectomy affects survival: A U.S. population-based analysis (2004-2012)Meera R Chappidi, Max Kates, Michael H Johnson, et al.Urology|January 17, 2016
Prostate-specific Antigen Mass Density--A Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity-related Prostate-specific Antigen HemodilutionOleksandr N Kryvenko, Mireya Diaz, Andres Matoso, et al.Pageof 39